Acta Med. 2001, 44: 77-79
https://doi.org/10.14712/18059694.2019.88
The Influence of Anticholinergic Drug Selection on the Effectiveness of Oximes Against Soman-Induced Supralethal Poisoning in Mice
References
1. J. Present view on toxidynamics of soman poisoning. Acta Med (Hradec Králové) 1996; 39:101-5.
2. Bajgar J, Fusek J, Vachek J. Treatment and prophylaxis against nerve agent poisoning. ASA Newslett 1994; 94-4:10-1.
3. J, Kassa J, Elsnerová I, Dejmenk L. Cholinesterase reactivators derived from pyridine-2-carbaldoxime. Coll Czech Chem Commun 1998; 63:199-204.
<https://doi.org/10.1135/cccc19980199>
4. RM. Review of oximes available for the treatment of nerve agent poisoning. J Appl Toxicol 1994; 14:317-31.
<https://doi.org/10.1002/jat.2550140502>
5. JH, Harris LW. Dealkylation as a mechanism for aging of cholineste- rase after poisoning with pinacolyl methylphosphonofluoridate. Biochem Pharmacol 1965; 14:641-9.
<https://doi.org/10.1016/0006-2952(65)90082-1>
6. T, Raveh L, Cohen G, Oz N, Baraness I, Balon A, Ashani Z, Shapira S. Distribution of 3H-soman in mice. Arch Toxicol 1985; 58:45-9.
<https://doi.org/10.1007/BF00292616>
7. J. Comparison of efficacy of two oximes (HI-6 and obidoxime) in soman poisoning in rats. Toxicology 1995; 101:167-74.
<https://doi.org/10.1016/0300-483X(95)03091-S>
8. J. Importance of cholinolytic drug selection for the efficacy of HI-6 against soman in rats. Toxicology 1997; 116:147-52.
<https://doi.org/10.1016/S0300-483X(96)03537-8>
9. Kassa J, Cabal J, Bajgar J, Szinicz L. The choice: HI-6, pralidoxime or obidoxime against nerve agents? ASA Newslett 1997; 97-4:16-8.
10. J. A comparison of the efficacy of new asymmetric bispyridinium oxime BI-6 with other oximes (obidoxime, HI-6) against soman in rats. Hum Exp Toxicol 1998; 17:331-5.
<https://doi.org/10.1177/096032719801700608>
11. J, Cabal J. A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with currently available oximes and H oximes against soman by in vitro and in vivo methods. Toxicology 1999; 132:111-8.
<https://doi.org/10.1016/S0300-483X(98)00146-2>
12. I, Stewart JR. A comparison of the efficacy of HI-6 and 2-PAM against soman, tabun, sarin and VX in the rabbit. Toxicol Lett 1994; 70:169-79.
<https://doi.org/10.1016/0378-4274(94)90121-X>
13. I, Menton R, Matthew C, Shutz M, Nalls C, Kelly S. Dose-response effects of atropine and HI-6 treatment of organophosphorus poisoning in guineapigs. Drug Chem Toxicol 1995; 18:119-31.
<https://doi.org/10.3109/01480549509014316>
14. TC. Organophosphate poisoning. Pharmacol Ther 1993; 58:51-66.
<https://doi.org/10.1016/0163-7258(93)90066-M>
15. JHJr, Shih T-M. Neuropharmacological mechanisms of nerve agentinduced seizure and neuropathology. Neurosci Biobehav Rev 1997; 21: 559-79.
<https://doi.org/10.1016/S0149-7634(96)00050-4>
16. S, Takase M, Kumagai F. Sarin poisoning in Japan. A clinical experience in Japan Self Defense Force (JSDF) Central Hospital. Int Rev Arm Ser 1996; 69:97-102.
17. M, Langenberg JP, Benschop H. New method for retrospective detection of exposure to organophosphorus anticholinesterases: application to alleged sarin victims of Japanese terrorists. Toxicol Appl Pharmacol 1997; 146:156-61.
<https://doi.org/10.1006/taap.1997.8243>
18. CG, Dua AK. Pharmacology of HI-6, an H series oximes. Can J Physiol Pharmacol 1989; 67:1183-9.
<https://doi.org/10.1139/y89-188>
19. T-M, Whalley ChE, Valdes JJ. A comparison of cholinergic effects of HI-6 and pralidoxime-2-chloride (2-PAM) in soman poisoning. Toxicol Lett 1991; 55:131-47.
20. T-M. Comparison of several oximes on reactivation of soman-inhibited blood, brain and tissue cholinesterase activity in rats. Arch Toxicol 1993; 67:637-46.
<https://doi.org/10.1007/BF01974071>
21. Tallarida R, Murray R. Manual of pharmacological calculation with computer programs. New York: Springer-Verlag, 1987:p.145.
22. J, Kassa J, Fusek J, Bajgar J. New possibilities of treatment of poisoning with organophosphorus compounds. Sbor věd Prací VLA JEP (Hradec Králové) 1993; 116:67-95.
